Retinopathy of Prematurity clinical trials
Access comprehensive clinical trial information for Retinopathy of Prematurity through Pure Global AI's free database. This collection includes 89 clinical trials across multiple phases including N/A, Phase 2, Phase 4. Currently, 14 trials are actively recruiting participants.
Research for Retinopathy of Prematurity is being conducted in United States of America, China, Canada,United States of America and 7+ other countries. Leading sponsors include Aristotle University Of Thessaloniki and Azienda Ospedaliero, Universitaria Meyer. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Pure Global AI provides free access to 89 clinical trials studying Retinopathy of Prematurity, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Aristotle University Of Thessaloniki, Azienda Ospedaliero, Universitaria Meyer, National Eye Institute (NEI), among others.